Dirk Arnold

Dirk Arnold

Medical Oncologist

Gastrointestinal Oncology

University Medical Center Hamburg-Eppendorf

Location Germany, Hamburg

Prof. Dirk Arnold is a leading medical oncologist specializing in gastrointestinal cancers, with extensive expertise in clinical research, targeted therapies, and multidisciplinary cancer treatment. He is internationally recognized for his contributions to colorectal cancer research, clinical trial development, and oncology guideline leadership.

Current Position

Medical Director, Hubertus Wald Tumor Center, University Cancer Center Hamburg (UCCH), University Medical Center Hamburg-Eppendorf, Germany

Education

  • MD, Universities of Ulm and Berlin, Germany (1996)
  • Specialist in Internal Medicine (2002)
  • Specialist in Hematology and Oncology (2009)
  • Specialist in Palliative Care (2009)
  • ESMO Certification (2006)

Area of Specialization

  • Gastrointestinal cancers (especially colorectal cancer)
  • Targeted therapies and antiangiogenic treatments
  • Clinical trials and oncology research networks
  • Multidisciplinary cancer treatment
  • Palliative oncology

Professional Experience

  • Senior Attending Physician & Head of Outpatient Department, Martin-Luther-University Halle-Wittenberg (2003–2010)
  • Chair, Central Clinical Trials Office, AIO (German Cancer Society) (2003–2008)
  • CEO, AIO Studien gGmbH, Berlin (2006–2008)
  • Clinical and research positions at Charité – Universitätsmedizin Berlin and Northwestern University, Chicago

Research & Scientific Activity

  • Focus on therapeutic strategies in gastrointestinal cancers
  • Work on targeted therapies including EGFR pathways and antiangiogenesis
  • Development and organization of large clinical research networks
  • Contributions to regional and interventional cancer therapies

Publications

  • Author of 70+ peer-reviewed publications, primarily in gastrointestinal oncology
  • Editorial board member of multiple oncology journals

Leadership & Memberships

  • Board Member, German Society for Hematology and Oncology (DGHO)
  • ESMO Guideline Representative for Colon Cancer
  • Member, EORTC Colorectal Cancer Task Force
  • Member, NCI Rectal Cancer Task Force (USA)
  • Member, German Cancer Society (DKG) and AIO leadership groups
  • Member: ASCO, ESMO

All information is sourced from publicly available materials.